Novo Nordisk faces US scrutiny over drug prices

US Senator Bernie Sanders is set to grill Novo Nordisk CEO Lars Jorgensen over the prices of Wegovy, the weight loss and diabetes drug, which can cost Americans more than $1,000 a month.

Share This Post: